A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics

Clinical and Experimental Metastasis

Volumn 27, Issue 2, 2010, Pages 83-90

  Hong, Yi ^a   Downey, Thomas ^b   Eu, Kong Weng ^a   Koh, Poh Koon ^a   Cheah, Peh Yean ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Partek Inc   (United States)

Author keywords

Connectivity map query; Early stage colorectal cancer; Genome wide expression profiling; Metastasis predictor; Mismatch repair proficient

Indexed keywords

GLYCYLHISTIDYLLYSINE; SECURININE;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MISMATCH REPAIR; MOLECULAR GENETICS; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BASE MISPAIRING; CASE CONTROL STUDY; CHINA; COLORECTAL TUMOR; GENETICS; PATHOLOGY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES;

EID: 77949907451     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9305-4     Document Type: Article

References (25)

1. Chia KS, Seow A, Lee HP et al (2000) Cancer incidence in Singapore 1993-1997. Singapore Cancer Registry Report: No. 5
2. Y Wang T Jatkoe Y Zhang, et al. 2004 Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J Clin Oncol 22 1564 1571 10.1200/JCO.2004.08.186 1:CAS:528:DC%2BD2cXpsVWmurw%3D 15051756 (Pubitemid 41079793)
3. De Gramont A, Boni C, Navarro M et al (2007) Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years. Proc AM Soc Clin Oncol 25:165s (suppl; abstr 4007)
4. PJ O'Dwyer SG Eckhardt DG Haller, et al. 2007 Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups J Clin Oncol 25 2313 2321 10.1200/JCO.2006.08.6900 17538178 (Pubitemid 46954660)
5. AH Bild A Potti JR Nevins 2006 Linking oncogenic pathways with therapeutic opportunities Nat Rev Cancer 6 735 741 10.1038/nrc1976 1:CAS:528:DC%2BD28XosVOmsb0%3D 16915294 (Pubitemid 44304232)
6. LJ van't Veer H Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536 10.1038/415530a (Pubitemid 34130608)
7. A Barrier P Boelle F Roser, et al. 2006 Stage II colon cancer prognosis prediction by tumor gene expression profiling J Clin Oncol 24 4685 4691 10.1200/JCO.2005.05.0229 1:CAS:528:DC%2BD28XhtFynsr3N 16966692 (Pubitemid 46630932)
8. KS Garman CR Acharya E Edelman, et al. 2008 A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities Proc Natl Acad Sci USA 105 19432 19437 10.1073/pnas.0806674105 1:CAS:528:DC%2BD1cXhsFamu7vL 19050079
9. M Kruhoffer JL Jensen P Laiho, et al. 2005 Gene expression signatures for colorectal cancer microsatellite status and HNPCC Br J Cancer 92 2240 2248 10.1038/sj.bjc.6602621 1:CAS:528:DC%2BD2MXltVygtL4%3D 15956967 (Pubitemid 40966263)
10. CP Giacomini SY Leung X Chen, et al. 2005 A gene expression signature of genetic instability in colon cancer Cancer Res 65 9200 9205 10.1158/0008-5472. CAN-04-4163 1:CAS:528:DC%2BD2MXhtFWmu77F 16230380 (Pubitemid 41507985)
11. T Watanabe T Kobunai E Toda, et al. 2006 Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers Cancer Res 66 9804 9808 10.1158/0008-5472.CAN-06-1163 1:CAS:528:DC%2BD28XhtVyiurzE 17047040 (Pubitemid 44672030)
12. Y Hong KS Ho KW Eu, et al. 2007 A susceptibility gene set for early onset colorectal cancer that integrates diverse signalling pathways: implication for tumorigenesis Clin Cancer Res 13 1107 1113 10.1158/1078-0432.CCR-06-1633 1:CAS:528:DC%2BD2sXhvF2hsLw%3D 17317818 (Pubitemid 46424049)
13. S Varma R Simon 2006 Bias in error estimation when using cross-validation for model selection BMC Bioinform 7 91 10.1186/1471-2105-7-91 (Pubitemid 43372006)
14. C Ambroise GJ McLachlan 2002 Selection bias in gene extraction on the basis of microarray gene-expression data Proc Nat Acad Sci USA 99 6562 6566 10.1073/pnas.102102699 1:CAS:528:DC%2BD38XjvFCktbo%3D 11983868 (Pubitemid 34526172)
15. J Lamb ED Crawford D Peck, et al. 2006 The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 1929 1935 10.1126/science.1132939 1:CAS:528:DC%2BD28XhtVSnsrbN 17008526 (Pubitemid 44497995)
16. J Lamb 2007 The connectivity map: a new tool for biomedical research Nat Rev Cancer 7 54 60 10.1038/nrc2044 1:CAS:528:DC%2BD28XhtlCht7nF 17186018 (Pubitemid 46020847)
17. S Ramaswamy KN Ross ES Lander, et al. 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 49 54 10.1038/ng1060 1:CAS:528:DC%2BD38XpvVeqs7w%3D 12469122 (Pubitemid 36068681)
18. S Jones W Chen G Parmigiani, et al. 2008 Comparative lesion sequencing provides insights into tumor evolution Proc Natl Acad Sci USA 105 4283 4288 10.1073/pnas.0712345105 1:CAS:528:DC%2BD1cXkt1WktLg%3D 18337506 (Pubitemid 351754372)
19. AJ Minn GP Gupta PM Siegel, et al. 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518 524 10.1038/nature03799 1:CAS:528: DC%2BD2MXmsFCgs7o%3D 16049480 (Pubitemid 41112921)
20. BS Wittner DC Sgroi PD Ryan, et al. 2008 Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort Clin Cancer Res 14 2988 2993 10.1158/1078-0432.CCR-07-4723 1:CAS:528:DC%2BD1cXmtVCmtLs%3D 18483364
21. E Vilar B Mukherjee R Kuick, et al. 2009 Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-Mammalian target of Rapamycin pathway Clin Cancer Res 15 2829 2839 1:CAS:528:DC%2BD1MXksV2ntrs%3D 19351759
22. 2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures Life Sci 67 2257 2265 10.1016/S0024-3205(00)00803-1 1:CAS:528:DC%2BD3cXntVygsrY%3D 11045606
23. L Pickart 2008 The human tri-peptide GHK and tissue remodelling J Biomater Sci Polym Ed 19 969 988 10.1163/156856208784909435 1:CAS:528: DC%2BD1cXps1Oju70%3D 18644225 (Pubitemid 351957385)
24. NA Dong ZL Gu WH Chou, et al. 1999 Securinine induced apoptosis in human leukemia HL-60 cells Zhongguo Yao Li Xue Bao 20 267 270 1:CAS:528: DyaK1MXhvVyjtrw%3D 10452105
25. K Lubick M Radke M Jutlia 2007 Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C.burnetii: comparison with TLR agonists J Leukoc Biol 82 1062 1069 10.1189/jlb.0407255 1:CAS:528: DC%2BD2sXht1KqsbzO 17698917 (Pubitemid 350133502)